Home│Site Map│Contact Us│ Search│
    繁體中文│English
    About Medigen
    Corporate Profile
    Corporate Vision
    Corporate Objective
    Management
    Business Activities
    New Drug Development
    Nucleic Acid Test
    Media Room
    Investor Relations
    Career
  1. ~Innovations for a Better Life~
  1. ‧2008-10-27
  2. Medigen Enters Into a Letter of Intent With Pacgen Biotech in Canada
  1. ‧2008-10-03
  2. Medigen Biotech Received Top Innovation Award by the Ministry of Economic Affairs (MOEA), Taiwan
  1. ‧2008-03-17
  2. Oncolys BioPharma Ties Up with Medigen Biotech. For Telomelysin
  1. ‧2008-03-05
  2. Oncolys BioPharma and Medigen Biotechnology Enter Strategic Alliance and Licensing Agreement
  1. ‧2007-11-28
  2. [Announcment] MBC Collaborates with Academia Sinica for Liver Cancer Development
  1. ‧2007-10-17
  2. MBC Co-ops with NTU for New Drug Development
  1. ‧2007-09-03
  2. Tetralogy of Complementary Double-Core Business Model
  1. ‧2007-08-06
  2. MBC Enters Blood Screening Market in China
  1. ‧2007-07-09
  2. Taiwanese Bid for Anti-Cancer Drug
  1. ‧2007-07-02
  2. Big Pharmas Favor BioMed-Industry in Taiwan
  1. ‧2007-06-16
  2. New Drug PI-88 Decreases Liver Cancer Recurrence to 34%
  1. ‧2007-06-15
  2. Liver Cancer Treatment Breakthrough by PI-88 Phase II Trial
  1. ‧2007-04-24
  2. New Drug PI-88 Prevents Liver Cancer Recurrence
  1. ‧2007-01-17
  2. MBC to Profit from PI-88 Ahead of Time
    11560 Room A, 14F., No.3, Yuancyu St., Nangang District, Taipei City 11560, Taiwan (R.O.C.)‧Copyright© 2007 Medigen Biotechnology Corp. All rights reserved.